Differential effects on morphine analgesia and naloxone antagonism by biogenic amine modifiers.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D008297:Male; D051379:Mice; D009020:Morphine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011955:Receptors, Drug; D012701:Serotonin / Q000378:metabolism
D001679:Biogenic Amines; D011955:Receptors, Drug; D010643:Phenoxybenzamine; D012701:Serotonin; D009270:Naloxone; D009020:Morphine; D001285:Atropine; D010830:Physostigmine; D011433:Propranolol; D004298:Dopamine